{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T15:09:46Z","timestamp":1760800186624},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We newly manufactured miso rich in angiotensin-converting enzyme (ACE) inhibitory activity (Marukome MK-34-1, shinki miso) and investigated its antihypertensive properties in rat models of genetic hypertension. ACE inhibitory activity was tenfold higher in shinki miso than in commercially available Marukome Nenrin miso (nenrin miso). The inhibitory activity of shinki miso was confined to &lt;3\u2009kDa fractions and was detected in several fractions with high polarity by C<jats:sub>18<\/jats:sub> high-performance liquid chromatography. Systolic blood pressure (SBP) increased age-dependently in stroke-prone spontaneously hypertensive rats (SHRSP\/Izm) given a 0.6% (w\/v) NaCl solution (salt solution group) that matched the salt content of the miso solutions. This SBP increase was attenuated in both the 5% nenrin and 5% shinki miso solution groups compared to the salt solution group. The reduction in SBP was greater in rats fed shinki than in rats fed nenrin miso. Similarly, in a salt-induced hypertension model with Dahl rats, the 5% nenrin miso solution attenuated the rising SBP observed in the salt solution group. Moreover, combining 5% nenrin miso with 5% shinki miso (2:1, v\/v) (awase miso group) significantly decreased the SBP per gram salt intake by 8% compared with the nenrin miso treatment. However, there were no differences in urinary Na excretion between the nenrin and awase miso groups. In conclusion, we produced a new miso with potent ACE inhibitory activity that reduced spontaneous and salt-induced hypertension. These results suggest that salt sensitivity is decreased by the addition of shinki miso to nenrin miso.<\/jats:p>","DOI":"10.1038\/s41440-018-0197-z","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T09:42:49Z","timestamp":1547113369000},"page":"790-800","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Newly manufactured Marukome MK-34-1 miso with angiotensin-converting enzyme inhibitory activity and its antihypertensive effects in genetic hypertensive rat models"],"prefix":"10.1038","volume":"42","author":[{"given":"Hiroe Sakuyama","family":"Tomari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misa","family":"Uchikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aki","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satomi","family":"Hirabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minami","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiki","family":"Itou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,10]]},"reference":[{"key":"197_CR1","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.nut.2011.09.010","volume":"28","author":"M Yoshinaga","year":"2012","unstructured":"Yoshinaga M, Toda N, Tamura Y, Terakado S, Ueno M, Otsuka K, et al. Japanese traditional Miso soup attenuates salt-induced hypertension and its organ damage in Dahl salt-sensitive rats. Nutrition. 2012;28:924\u201331.","journal-title":"Nutrition"},{"key":"197_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3109\/10641963.2013.827702","volume":"6","author":"D Du","year":"2014","unstructured":"Du D, Yoshinaga M, Sonoda M, Kawakubo K, Uehara Y. Blood pressure reduction by Japanese traditional Miso is associated with increased diuresis and natriuresis through dopamine system in Dahl salt-sensitive rats. Clin Exp Hypertens. 2014;6:359\u201366.","journal-title":"Clin Exp Hypertens"},{"key":"197_CR3","first-page":"693","volume":"6","author":"N Shimizu","year":"2015","unstructured":"Shimizu N, Du D, Sakuyama H, Ito Y, Sonoda M, Kawakubo K, et al. Continuous subcutaneous administration of Miso extracts attenuates salt-induced hypertension in Dahl salt-sensitive rats. Food Nutr Sci. 2015;6:693\u2013702.","journal-title":"Food Nutr Sci"},{"key":"197_CR4","first-page":"1601","volume":"44","author":"M Kitagawa","year":"2016","unstructured":"Kitagawa M, Itoh K, Yamada M, Koike S, Yamamoto T, Uehara Y. Long term intake of miso soup unaffected blood pressure in subjects with normal or stage I hypertension-double blind comparative intervention trial. Jpn Pharmacol Ther. 2016;44:1601\u201312. (abstract in English)","journal-title":"Jpn Pharmacol Ther"},{"key":"197_CR5","first-page":"1","volume":"10","author":"H Sakuyama","year":"2017","unstructured":"Sakuyama H, Tachizaki N, Nanmo A, Yamada K, Uehara Y. The influence of intake of daily Miso soup on blood pressure in humans-The results of 5-year observational study. J Jpn Soc Med Use Funct Foods. 2017;10:1\u20138. (abstract in English).","journal-title":"J Jpn Soc Med Use Funct Foods"},{"key":"197_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0024-3205(99)00569-X","volume":"66","author":"R Nevala","year":"2000","unstructured":"Nevala R, Vaskonen T, Vehniainen J, Korpela R, Vapaatalo H. Soy based diet attenuates the development of hypertension when compared to casein based diet in spontaneously hypertensive rat. Life Sci. 2000;66:115\u201324.","journal-title":"Life Sci"},{"key":"197_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3136\/nskkk.56.6","volume":"56","author":"T Takenaka","year":"2009","unstructured":"Takenaka T, Murayama T, Takenaka Y. Isolation of nicotianamine from soybean broth and changes in its content in the soybean steaming process. Nippon Shokuhin Kagaku Kogaku Kaishi. 2009;56:6\u201313. (abstract in English)","journal-title":"Nippon Shokuhin Kagaku Kogaku Kaishi"},{"key":"197_CR8","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3181\/00379727-70-17028","volume":"70","author":"M Friedman","year":"1949","unstructured":"Friedman M, Freed SC. Microphonic manometer for indirect determination of systolic blood pressure in the rat. Proc Soc Exp Biol Med. 1949;70:670\u20132.","journal-title":"Proc Soc Exp Biol Med"},{"key":"197_CR9","unstructured":"Kitagawa M, Tada K, Yamada M, Haruno R, Higashi T, Koike S. Purification and characterization of angiotensin I converting enzyme inhibitor from short-term fermented Miso. The 68th Annual Meeting of the Society of Biotechnology of Japan. Toyama, Japan. 2016."},{"issue":"Pt 5","key":"197_CR10","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1107\/S0108270195016180","volume":"52","author":"A1 Vrielink","year":"1996","unstructured":"Vrielink A1, Obel-Jorgensen A, Codding PW. Hippuryl-L-histidyl-L-leucine, a substrate for angiotensin converting enzyme. Acta Crystallogr C. 1996;52(Pt 5):1300\u20132.","journal-title":"Acta Crystallogr C"},{"key":"197_CR11","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1038\/nprot.2006.305","volume":"1","author":"SL Schwager","year":"2006","unstructured":"Schwager SL, Carmona AK, Sturrock ED. A high-throughput fluorimetric assay for angiotensin I-converting enzyme. Nat Protoc. 2006;1:1961\u20134.","journal-title":"Nat Protoc"},{"key":"197_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1291\/hypres.15.17","volume":"15","author":"Y Uehara","year":"1992","unstructured":"Uehara Y, Kawabata Y, Shirahase H, Wada K, Hashizume Y, Morishita S, et al. Radical scavenging properties of indapamide and renal protection in Dahl salt-sensitive rats. Hyperten Res. 1992;15:17\u201326.","journal-title":"Hyperten Res"},{"key":"197_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1291\/hypres.18.245","volume":"18","author":"Y Uehara","year":"1995","unstructured":"Uehara Y, Hirawa N, Takeda T, Numabe A, Kawabata Y, Nagoshi H, et al. Possible linkage between injury and cardiac remodeling in Dahl salt-sensitive rats treated with a calcium channel antagonist, benidipine. Hypertens Res. 1995;18:245\u201353.","journal-title":"Hypertens Res"},{"key":"197_CR14","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1161\/01.CIR.0000030935.89559.04","volume":"106","author":"UP Jorde","year":"2002","unstructured":"Jorde UP, Vittorio T, Katz SD, Colombo PC, Latif F, Le Jemtel TH. Elevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure. Circulation. 2002;106:1055\u20137. https:\/\/doi.org\/10.1161\/01.CIR.0000030935.89559.04","journal-title":"Circulation"},{"issue":"9","key":"197_CR15","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/ncpneph0575","volume":"3","author":"Andrew S Bomback","year":"2007","unstructured":"Bomback AS, Klemmer PJ. The incidence and implications of aldosterone breakthrough. Nat Clin Pract Nephrol. 2007;3:486\u201392. https:\/\/doi.org\/10.1038\/ncpneph0575","journal-title":"Nature Clinical Practice Nephrology"},{"key":"197_CR16","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1161\/01.HYP.32.3.488","volume":"32","author":"M Zafari","year":"1998","unstructured":"Zafari M, Ushio-Fukai M, Akers M, Yin Q, Shah A, Harrison DG, et al. Role of NADH\/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension. 1998;32:488\u201395.","journal-title":"Hypertension"},{"key":"197_CR17","doi-asserted-by":"publisher","first-page":"10844","DOI":"10.1021\/acs.jafc.7b05026","volume":"65","author":"Z Wang","year":"2017","unstructured":"Wang Z, Cui Y, Liu P, Zhao Y, Wang L, Liu Y, et al. Small peptides isolated from enzymatic hydrolyzate of fermented soybean meal promote endothelium-independent vasorelaxation and ACE inhibition. J Agric Food Chem. 2017;65:10844\u201350.","journal-title":"J Agric Food Chem"},{"key":"197_CR18","doi-asserted-by":"publisher","first-page":"H201","DOI":"10.1111\/j.1750-3841.2011.02362.x","volume":"76","author":"T Nakahara","year":"2011","unstructured":"Nakahara T, Sugimoto K, Sano A, Yamaguchi H, Katayama H, Uchida R. Antihypertensive mechanism of a peptide-enriched soy sauce-like seasoning: the active constituents and its suppressive effect on renin-angiotensin-aldosterone system. J Food Sci. 2011;76:H201\u20136.","journal-title":"J Food Sci"},{"key":"197_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jbiosc.2009.03.007","volume":"108","author":"K Inoue","year":"2009","unstructured":"Inoue K, Gotou T, Kitajima H, Mizuno S, Nakazawa T, Yamamoto N. Release of antihypertensive peptides in miso paste during its fermentation, by the addition of casein. J Biosci Bioeng. 2009;108:111\u20135.","journal-title":"J Biosci Bioeng"},{"key":"197_CR20","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1161\/01.CIR.95.3.588","volume":"95","author":"JB Laursen","year":"1997","unstructured":"Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation. 1997;95:588\u201393.","journal-title":"Circulation"},{"key":"197_CR21","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1161\/01.RES.74.6.1141","volume":"74","author":"KK1 Griendling","year":"1994","unstructured":"Griendling KK1, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141\u20138.","journal-title":"Circ Res"},{"key":"197_CR22","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1097\/00004872-199408000-00008","volume":"12","author":"N Hirawa","year":"1994","unstructured":"Hirawa N, Uehara Y, Kawabata Y, Nagata T, Ohshima N, Ono H, et al. Mechanistic analysis of renal protection by angiotensin-converting enzyme inhibitor in Dahl salt-sensitive rats. J Hypertens. 1994;12:909\u20138.","journal-title":"J Hypertens"},{"key":"197_CR23","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1146\/annurev.pharmtox.010909.105610","volume":"50","author":"M Bader","year":"2010","unstructured":"Bader M. Tissue renin-angiotensin-aldosterone systems: targets for pharmacological therapy. Annu Rev Pharmacol Toxicol. 2010;50:439\u201365.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"197_CR24","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1161\/CIRCRESAHA.109.212837","volume":"106","author":"AP Owens","year":"2010","unstructured":"Owens AP, Subramanian, Moorleghen JJ, Guo Z, McNamara CA, Cassis LA, et al. Angiotensin II induces a region-specific hyperplasia of the ascending aorta through regulation of inhibitor of differentiation 3. Circ Res. 2010;106:611\u20139.","journal-title":"Circ Res"},{"key":"197_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/00004872-199501000-00013","volume":"13","author":"N Hirawa","year":"1995","unstructured":"Hirawa N, Uehara Y, Kawabata Y, Ohshima N, Ono H, Nagata T, et al. Subpressodose of angiotensin II increases susceptibility of the haemodynamic injury of blood pressure in Dahl salt-sensitive rats. J Hypertens. 1995;13:81\u201390.","journal-title":"J Hypertens"},{"key":"197_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0090-6980(93)90098-R","volume":"46","author":"Y Uehara","year":"1993","unstructured":"Uehara Y, Takada S, Hirawa N, Kawabata Y, Nagata T, Numabe A, et al. De novo synthesis of phospholipase A2 and prostacyclin production by proliferating rat smooth muscle cells. Prostaglandins. 1993;46:331\u201346.","journal-title":"Prostaglandins"},{"key":"197_CR27","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1097\/00004872-199310000-00011","volume":"11","author":"Y Uehara","year":"1993","unstructured":"Uehara Y, Numabe A, Kawabata Y, Takada S, Hirawa N, Nagata T, et al. Inhibition of protein synthesis and antiproliferating effect by angiotensin converting enzyme inhibitor in rat vascular smooth muscle cells. J Hypertens. 1993;11:1073\u201381.","journal-title":"J Hypertens"},{"key":"197_CR28","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/00004872-200404000-00018","volume":"22","author":"B Somoza","year":"2004","unstructured":"Somoza B, Gonz\u00e1lez C, Cachofeiro V, Lahera V, Fern\u00e1ndez-Alfonso MS. Chronic l-arginine treatment reduces vascular smooth muscle cell hypertrophy through cell cycle modifications in spontaneously hypertensive rats. J Hypertens. 2004;22:751\u20138.","journal-title":"J Hypertens"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0197-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0197-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0197-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:20:13Z","timestamp":1684617613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-018-0197-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,10]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["197"],"URL":"https:\/\/doi.org\/10.1038\/s41440-018-0197-z","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,10]]},"assertion":[{"value":"10 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}